03:19 AM EDT, 07/25/2024 (MT Newswires) -- Michael J. LaBarre, Chief Technical Officer & Senior Vice President, on July 23, 2024, sold 20,000 shares in Halozyme Therapeutics ( HALO ) for $1,100,023. Following the Form 4 filing with the SEC, LaBarre has control over a total of 168,176 shares of the company, with 168,176 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588924020055/xslF345X03/form4-07242024_090711.xml

Price: 56.42, Change: +1.27, Percent Change: +2.30